Načítá se...
Feasibility study of short hydration using oral rehydration solution in cisplatin including chemotherapy of lung cancer
BACKGROUND: Cisplatin (CDDP) is used as a key anticancer drug for solid cancers, including lung cancer. However, a large quantity of fluid replacement is required to prevent renal dysfunction. This requirement have made outpatient chemotherapies including CDDP administration less popular among the a...
Uloženo v:
Vydáno v: | J Pharm Health Care Sci |
---|---|
Hlavní autoři: | , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
BioMed Central
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4779197/ https://ncbi.nlm.nih.gov/pubmed/26949541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-016-0041-z |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|